298 related articles for article (PubMed ID: 35346200)
61. Prognostic value of the fibrinogen-to-platelet ratio as an inflammatory and coagulative index in patients with gastric cancer.
Wakatsuki K; Matsumoto S; Migita K; Kunishige T; Nakade H; Miyao S; Sho M
Surg Today; 2019 Apr; 49(4):334-342. PubMed ID: 30411155
[TBL] [Abstract][Full Text] [Related]
62. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
[TBL] [Abstract][Full Text] [Related]
63. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
64. Diagnostic Values of the Prealbumin-to-Fibrinogen, Albumin-to-Fibrinogen, and Monocyte-to-Lymphocyte Ratios in Gastric Cancer.
Zhang L; Qin S; Chen H; Hu Z; Li S
Ann Clin Lab Sci; 2021 May; 51(3):385-392. PubMed ID: 34162569
[TBL] [Abstract][Full Text] [Related]
65. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
[TBL] [Abstract][Full Text] [Related]
66. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
67. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
[TBL] [Abstract][Full Text] [Related]
68. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.
Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P
Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301
[TBL] [Abstract][Full Text] [Related]
69. Albumin-to-fibrinogen ratio is an independent prognostic parameter in de novo non-M3 acute myeloid leukemia.
Ding Y; Qi X; Li Y; Sun Y; Wan J; Luo C; Huang Y; Li Q; Wu G; Zhu X; Xu S
Clin Exp Med; 2023 Dec; 23(8):4597-4608. PubMed ID: 37914966
[TBL] [Abstract][Full Text] [Related]
70. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
[TBL] [Abstract][Full Text] [Related]
71. Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer.
Shiomi K; Naito M; Sato T; Nakamura T; Nakashima H; Naito M; Mikubo M; Matsui Y; Watanabe M; Satoh Y
Ann Med Surg (Lond); 2017 Aug; 20():19-25. PubMed ID: 28702182
[TBL] [Abstract][Full Text] [Related]
72. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of C-reactive protein and fibrinogen in comparison to CEA and CA72-4 as diagnostic biomarkers for colorectal cancer.
Bu F; Cao S; Deng X; Zhang Z; Feng X
Heliyon; 2023 May; 9(5):e16092. PubMed ID: 37215813
[TBL] [Abstract][Full Text] [Related]
74. Diagnostic Accuracy of Elevated Serum Carcinoembryonic Antigen for Recurrence in Postoperative Stage II Colorectal Cancer Patients: Comparison With Stage III.
Kim HS; Lee MR
Ann Coloproctol; 2013 Aug; 29(4):155-9. PubMed ID: 24032116
[TBL] [Abstract][Full Text] [Related]
75. Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer.
Li S; Zhang D; Zeng S; Wu T; Wang Y; Zhang H; Wang B; Hu X
J Cancer; 2021; 12(19):5864-5873. PubMed ID: 34475999
[No Abstract] [Full Text] [Related]
76. Pan-immune-inflammation value is associated with the clinical stage of colorectal cancer.
Zhao H; Chen X; Zhang W; Cheng D; Lu Y; Wang C; Li J; You L; Yu J; Guo W; Li Y; Huang Y
Front Surg; 2022; 9():996844. PubMed ID: 36034356
[TBL] [Abstract][Full Text] [Related]
77. Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer.
Kim CW; Ha YJ; Tak KH; Roh SA; Kim SK; Kim SY; Kim YS; Cho DH; Kim JC
Anticancer Res; 2021 Sep; 41(9):4651-4658. PubMed ID: 34475094
[TBL] [Abstract][Full Text] [Related]
78. Prognostic value of preoperative carcinoembryonic antigen and D-dimer concentrations in patients undergoing curative resection for colorectal cancer.
Ojima Y; Harano M; Sumitani D; Yoshimitsu M; Okajima M
Surg Today; 2021 Jul; 51(7):1108-1117. PubMed ID: 33386463
[TBL] [Abstract][Full Text] [Related]
79. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
[TBL] [Abstract][Full Text] [Related]
80. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
